Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger-Fasching

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of the Neurological Sciences|April 30, 1998
677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor strokeW Lalouschek, S Aull, L Korninger, et al.
Blut|November 1, 1984
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myelomaH Gössinger, P Bettelheim, E Neumann, et al.
Thrombosis and Haemostasis|June 30, 1989
High risk of acquired immune deficiency syndrome (AIDS) and of AIDS related complex (ARC) in hemophiliacs seropositive for more than 5 yearsC Stain, I Pabinger-Fasching, K Guggenberger, et al.
British Journal of Haematology|January 1, 1994
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study GroupP M Mannucci, A Gringeri, G Savidge, et al.
Hamostaseologie|May 1, 2009
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]Günter Auerswald, W Muntean, B Kemkes-Matthes, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2013
Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillationM K Freynhofer, D F Draxler, S C Gruber, et al.
Thrombosis and Haemostasis|April 22, 1985
HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDST L Chorba, J M Jason, R B Ramsey, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of the Neurological Sciences|April 30, 1998
677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor strokeW Lalouschek, S Aull, L Korninger, et al.
Blut|November 1, 1984
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myelomaH Gössinger, P Bettelheim, E Neumann, et al.
Thrombosis and Haemostasis|June 30, 1989
High risk of acquired immune deficiency syndrome (AIDS) and of AIDS related complex (ARC) in hemophiliacs seropositive for more than 5 yearsC Stain, I Pabinger-Fasching, K Guggenberger, et al.
British Journal of Haematology|January 1, 1994
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study GroupP M Mannucci, A Gringeri, G Savidge, et al.
Hamostaseologie|May 1, 2009
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]Günter Auerswald, W Muntean, B Kemkes-Matthes, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2013
Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillationM K Freynhofer, D F Draxler, S C Gruber, et al.
Thrombosis and Haemostasis|April 22, 1985
HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDST L Chorba, J M Jason, R B Ramsey, et al.
Pageof 4